Springworks Therapeutics Stock Investor Sentiment

SWTX Stock  USD 49.22  0.88  1.76%   
Slightly above 70% of SpringWorks Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding SpringWorks Therapeutics suggests that many traders are alarmed. SpringWorks Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in SpringWorks Therapeutics. The current market sentiment, together with SpringWorks Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use SpringWorks Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

30

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use SpringWorks Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward SpringWorks Therapeutics.
SpringWorks Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SpringWorks daily returns and investor perception about the current price of SpringWorks Therapeutics as well as its diversification or hedging effects on your existing portfolios.

SpringWorks Historical Sentiment

Although SpringWorks Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding SpringWorks, such as negative comments on social media and news outlets, may cause fear in the market and push SpringWorks Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of SpringWorks.
  

SpringWorks Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards SpringWorks Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

SpringWorks Therapeutics Historical Investor Sentiment

Investor biases related to SpringWorks Therapeutics' public news can be used to forecast risks associated with an investment in SpringWorks. The trend in average sentiment can be used to explain how an investor holding SpringWorks can time the market purely based on public headlines and social activities around SpringWorks Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
SpringWorks Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for SpringWorks Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average SpringWorks Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on SpringWorks Therapeutics.

SpringWorks Therapeutics Maximum Pain Price across 2024-04-19 Option Contracts

SpringWorks Therapeutics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of SpringWorks Therapeutics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of SpringWorks Therapeutics' options.
2 days ago at news.google.com         
SpringWorks Therapeutics, Inc. Receives 68.00 Consensus PT from Analysts - MarketBeat
Google News at Macroaxis
few days ago at finance.yahoo.com         
Heres Why You Should Hold McKesson in Your Portfolio
Yahoo News
over a week ago at news.google.com         
SpringWorks Therapeutics, Inc. Position Boosted by Walleye Capital LLC - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Will SpringWorks Therapeutics Inc Stay at the Top of the Healthcare Sector - InvestorsObserver
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
SpringWorks Therapeutics Price Target Raised to 74.00 at HC Wainwright
news
over two weeks ago at thelincolnianonline.com         
JPMorgan Chase Co. Boosts SpringWorks Therapeutics Price Target to 74.00
news
over two weeks ago at thelincolnianonline.com         
SpringWorks Therapeutics Reaches New 52-Week High at 53.92
news
over two weeks ago at news.google.com         
HC Wainwright Co Analyst Reiterates Buy Rating and Increases Price Target for SpringWorks Therapeuti...
Google News at Macroaxis
over three weeks ago at news.google.com         
Is SpringWorks Therapeutics Inc Stock a Good Value Tuesday - InvestorsObserver
Google News at Macroaxis
over three weeks ago at investing.com         
SpringWorks begins rolling FDA submission for rare disease drug
Investing News at Macroaxis
over three weeks ago at globenewswire.com         
SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdame...
Macroaxis News: globenewswire.com
over three weeks ago at thelincolnianonline.com         
Barclays Raises SpringWorks Therapeutics Price Target to 63.00
news
over three weeks ago at investing.com         
SpringWorks seeks EU approval for desmoid tumor treatment
Investing News at Macroaxis
over three weeks ago at thelincolnianonline.com         
SpringWorks Therapeutics Posts Quarterly Earnings Results
news
over three weeks ago at benzinga.com         
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization ...
benzinga news
Far too much social signal, news, headlines, and media speculation about SpringWorks Therapeutics that are available to investors today. That information is available publicly through SpringWorks media outlets and privately through word of mouth or via SpringWorks internal channels. However, regardless of the origin, that massive amount of SpringWorks data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of SpringWorks Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of SpringWorks Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to SpringWorks Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive SpringWorks Therapeutics alpha.

SpringWorks Therapeutics Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Is SpringWorks Therapeutics Inc Stock a Good Value Tuesday - InvestorsObserver
01/23/2024
2
SpringWorks Therapeutics Trading Up 2.3
02/15/2024
3
Exercise or conversion by Daniel Pichl of 15000 shares of SpringWorks Therapeutics subject to Rule 16b-3
02/20/2024
4
Wedbush Raises SpringWorks Therapeutics Price Target to 70.00
02/26/2024
5
SpringWorks Therapeutics Q4 Earnings Snapshot
02/27/2024
6
FY2023 EPS Estimates for SpringWorks Therapeutics, Inc. Raised by Analyst
02/28/2024
7
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with...
02/29/2024
8
Barclays Raises SpringWorks Therapeutics Price Target to 63.00
03/04/2024
9
SpringWorks Therapeutics Reaches New 52-Week High at 53.92
03/08/2024
10
Will SpringWorks Therapeutics Inc Stay at the Top of the Healthcare Sector - InvestorsObserver
03/15/2024
11
SpringWorks Therapeutics, Inc. Receives 68.00 Consensus PT from Analysts - MarketBeat
03/26/2024
When determining whether SpringWorks Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SpringWorks Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Springworks Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Springworks Therapeutics Stock:

Complementary Tools for SpringWorks Stock analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is SpringWorks Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.15)
Revenue Per Share
0.086
Return On Assets
(0.32)
Return On Equity
(0.55)
The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.